Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)

CUSIP: 28658R106

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
68,580,003
Total 13F shares
44,576,107
Share change
-5,312,025
Total reported value
$89,598,934
Price per share
$2.01
Number of holders
66
Value change
-$10,311,694
Number of buys
23
Number of sells
45

Security key

28658R106

Report period

Q3 2025

Institutions

66

Top holders

10

Top shareholders of CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AI ETI LLC
3/4/5
10%+ Owner
class O/S missing
5,009,400
$62,617,500 12 Aug 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
46%
31,419,267
$38,959,891 30 Jun 2025
13F
Pontifax Management 4 G.P. (2015) Ltd.
13D/G
Pontifax VI G.P. L.P.
7.7%
5,206,380
$12,911,822 $0 27 Jun 2024
CANTOR FITZGERALD, L. P.
13F
Individual
3.6%
2,502,531
$3,103,138 30 Jun 2025
13F
CITIGROUP INC
13F
Company
2.4%
1,611,887
$1,998,740 30 Jun 2025
13F
Affinity Asset Advisors, LLC
13F
Company
2.2%
1,500,000
$1,860,000 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
1.9%
1,331,250
$1,650,750 30 Jun 2025
13F
Deep Track Capital, LP
13F
Company
1.5%
1,040,115
$1,289,743 30 Jun 2025
13F
Kynam Capital Management, LP
13F
Company
1.5%
1,028,341
$1,275,143 30 Jun 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
1.5%
1,000,000
$1,240,000 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
1.3%
877,969
$1,088,681 30 Jun 2025
13F
DIADEMA PARTNERS LP
13F
Company
1%
702,135
$870,647 30 Jun 2025
13F
Peapod Lane Capital LLC
13F
Company
0.81%
555,667
$689,017 30 Jun 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.8%
547,965
$680,000 30 Jun 2025
13F
Brett Kaplan
3/4/5
Chief Operating Officer
mixed-class rows
577,500
mixed-class rows
$618,450 13 Jan 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.72%
495,500
$614,420 30 Jun 2025
13F
Alyeska Investment Group, L.P.
13F
Company
0.71%
485,364
$601,851 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.7%
480,078
$595,297 30 Jun 2025
13F
NAN FUNG TRINITY (HK) Ltd
13F
Company
0.68%
463,654
$574,931 30 Jun 2025
13F
Shay Capital LLC
13F
Company
0.61%
415,000
$514,600 30 Jun 2025
13F
UBS Group AG
13F
Company
0.56%
382,482
$474,278 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.45%
311,721
$386,711 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.31%
210,122
$260,551 30 Jun 2025
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.31%
209,837
$260,198 30 Jun 2025
13F
Valerie Morisset
3/4/5
EVP, R&D AND CSO
mixed-class rows
41,515
mixed-class rows
$249,910 19 Jul 2024
GOLDMAN SACHS GROUP INC
13F
Company
0.29%
201,312
$249,627 30 Jun 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.26%
179,591
$222,693 30 Jun 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.22%
148,180
$183,744 30 Jun 2025
13F
Persistent Asset Partners Ltd
13F
Company
0.21%
145,179
$180,022 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.21%
141,424
$175,366 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.2%
138,392
$171,606 30 Jun 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.2%
134,300
$166,532 30 Jun 2025
13F
Y-Intercept (Hong Kong) Ltd
13F
Company
0.19%
127,952
$158,660 30 Jun 2025
13F
ADAR1 Capital Management, LLC
13F
Company
0.17%
119,320
$147,957 30 Jun 2025
13F
Stonepine Capital Management, LLC
13F
Company
0.17%
116,147
$144,022 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.15%
103,100
$127,844 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.15%
99,459
$123,329 30 Jun 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.14%
94,900
$117,676 30 Jun 2025
13F
TD ASSET MANAGEMENT INC
13F
Company
0.13%
89,400
$110,856 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.09%
62,358
$77,324 30 Jun 2025
13F
Cubist Systematic Strategies, LLC
13F
Company
0.09%
62,176
$77,098 30 Jun 2025
13F
Emily Pimblett
3/4/5
SVP, Finance & CAO
mixed-class rows
133,888
mixed-class rows
$63,821 -$1,540 18 Jun 2025
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.06%
38,900
$48,236 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
0.05%
36,738
$45,555 30 Jun 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.05%
34,310
$42,544 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.04%
29,377
$36,427 30 Jun 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.04%
28,890
$35,823 30 Jun 2025
13F
Jain Global LLC
13F
Company
0.04%
25,693
$31,859 30 Jun 2025
13F
Squarepoint Ops LLC
13F
Company
0.03%
19,640
$24,354 30 Jun 2025
13F
HRT FINANCIAL LP
13F
Company
0.03%
18,529
$22,000 30 Jun 2025
13F

Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q3 2025

As of 30 Sep 2025, Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,576,107 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, Affinity Asset Advisors, LLC, Kynam Capital Management, LP, TANG CAPITAL MANAGEMENT LLC, BlackRock, Inc., Peapod Lane Capital LLC, CANTOR FITZGERALD, L. P., RENAISSANCE TECHNOLOGIES LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 67 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
68
Q3 2025 holders
66
Holder diff
-2
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .